AJP - Lung Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (August 13, 2004). doi:10.1152/ajplung.00137.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/6/L1333    most recent
00137.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ochs, M.
Right arrow Articles by Hawgood, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ochs, M.
Right arrow Articles by Hawgood, S.
Submitted on April 13, 2004
Accepted on August 9, 2004

GM-CSF mediates alveolar epithelial type II cell changes but not emphysema-like pathology in SP-D deficient mice

Matthias Ochs1*, Lars Knudsen2, Lennell Allen3, Amber Stumbaugh3, Stacey Levitt3, Jens R. Nyengaard4, and Samuel Hawgood3

1 Department of Anatomy, Division of Electron Microscopy, University of Goettingen, Goettingen, Germany; Cardiovascular Research Institute and Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA; Stereological Research Laboratory and Electron Microscopy Laboratory, University of Aarhus, Aarhus, Denmark
2 Department of Anatomy, Division of Electron Microscopy, University of Goettingen, Goettingen, Germany
3 Cardiovascular Research Institute and Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA
4 Stereological Research Laboratory and Electron Microscopy Laboratory, University of Aarhus, Aarhus, Denmark

* To whom correspondence should be addressed. E-mail: mochs{at}gwdg.de.

Surfactant protein D (SP-D) is a member of the collectin subfamily of C-type lectins, patternrecognition proteins participating in the innate immune response. Gene-targeted mice deficient in SP-D develop abnormalities in surfactant homeostasis, hyperplasia of alveolar epithelial type II cells and emphysema-like pathology. Granulocyte-macrophage colony-stimulating factor (GMCSF) is required for terminal differentiation and subsequent activation of alveolar macrophages, including the expression of matrix metalloproteinases and reactive oxygen species, factors thought to contribute to lung remodeling. Type II cells also express the GM-CSF receptor. Thus, we hypothesized GM-CSF might mediate some or all of the cellular and structural abnormalities in the lungs of SP-D deficient mice. To test this, SP-D (D-G+) and GM-CSF (D+G-) single knockout mice as well as double knockout mice deficient for both SP-D and GM-CSF (D-G-) were analyzed by design-based stereology. Compared to wild type, D-G+ as well as D+G- mice show decreased alveolar numbers, increased alveolar sizes and decreased alveolar epithelial surface areas. These emphysema-like changes are present to a greater extent in D-G- mice. D-G+ mice develop type II cell hyperplasia and hypertrophy with increased intracellular surfactant pools while D+G- mice have smaller type II cells with decreased intracellular surfactant pools. In contrast to the emphysematous changes, the type II cell alterations are mostly corrected in D-Gmice. These results indicate that GM-CSF-dependent macrophage activity is not necessary for emphysema development in SP-D deficient mice, but that type II cell metabolism and proliferation are, either directly or indirectly, regulated by GM-CSF in this model.




This article has been cited by other articles:


Home page
Integr. Comp. Biol.Home page
E. Spinelli Oliveira, J. T. Hancock, M. Hermes-Lima, D. A. Isola, M. Ochs, J. Yu, and D. Wilhem Filho
Implications of dealing with airborne substances and reactive oxygen species: what mammalian lungs, animals, and plants have to say?
Integr. Comp. Biol., October 1, 2007; 47(4): 578 - 591.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. J. Greenlee, Z. Werb, and F. Kheradmand
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Physiol Rev, January 1, 2007; 87(1): 69 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. R. Weibel, C. C. W. Hsia, and M. Ochs
How much is there really? Why stereology is essential in lung morphometry
J Appl Physiol, January 1, 2007; 102(1): 459 - 467.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
H. Fehrenbach
Animal models of pulmonary emphysema: a stereologist's perspective
Eur. Respir. Rev., December 1, 2006; 15(101): 136 - 147.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. R. Weibel, H. Parameswaran, A. Majumdar, S. Ito, A. M. Alencar, B. Suki, W. Mitzner, C. C. W. Hsia, H. Fehrenbach, and J. P. Butler
Morphological Quantitation of Emphysema: A Debate
J Appl Physiol, April 1, 2006; 100(4): 1419 - 1421.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.